LACTOSE FOR INHALATION
MICRO-SPHERE SA's know-how is particularly aimed at the development of inhalation products with pulmonary and systemic action.
Lacto-Sphere® is lactose for inhalation specifically developed by MICRO-SPHERE as a carrier for Dry Powder Inhaler (DPI) formulations. It is produced at cGMP compliance.
It meets the requirements of the United States, the European and Janapese Pharmacopoeias monographs for Lactose monohydrate.
- Lacto-Sphere®MM3 is a fine lactose produced by micronisation (jet-mill) D50:2µm-4µm. Added to DPI formulations in order to prevent the unspecific adhesion of the active ingredient particles to the high-energy site of the surface of more coarse lactose crystals.
- Lacto-Sphere®MM50 is medium size basic carrier (by sieving) D50: 40 µm-60µm
Key benefits of Lacto-Sphere® are:
- Sourced from BSE/TSE free country (US)
- Production under cGMP conditions
DMF - MSDS - Certificate of origin
Statement of compliance with "Note for guidance on minimising the risk of transmitting animal spongiform encephalopathy agents" (EMEA/410/01/Rev.2).
Statement of absence of GMO's material in the final product.
On our Lacto-Sphere® we guarantee a 2 years stability.